GDC 0134Alternative Names: GDC-0134; RG6000
Latest Information Update: 02 Feb 2016
At a glance
- Originator Genentech
- Mechanism of Action Neuron modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Amyotrophic lateral sclerosis
Most Recent Events
- 01 Jan 2016 Phase-I clinical trials in Amyotrophic lateral sclerosis in USA (unspecified route)